TWST - Twist Bioscience Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Twist Bioscience Corporation

681 Gateway Boulevard
South San Francisco, CA 94080
United States

IndustryDiagnostics & Research
Full Time Employees414

Key Executives

NameTitlePayExercisedYear Born
Dr. Emily Marine LeproustCo-Founder, Pres, CEO & Director935.79kN/A1973
Mr. James M. ThorburnChief Financial Officer597.2kN/A1955
Dr. Patrick John FinnChief Commercial Officer558.68kN/A1971
Mr. William Charles BanyaiCOO & DirectorN/AN/A1954
Mr. Bill PeckChief Technology OfficerN/AN/A1960
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. Twist Bioscience Corporation has collaboration agreements with Pandion Therapeutics, Inc. and Schrödinger Inc. The company was founded in 2013 and is headquartered in South San Francisco, California.

Corporate Governance

Twist Bioscience Corporation’s ISS Governance QualityScore as of October 4, 2019 is 9. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.